Lesions in ryanodine channels in smooth muscle cells exposed to oxidized low density lipoprotein

Hamid Massaeli, J. Alejandro Austria, Grant N. Pierce

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The purpose of the present investigation was to investigate the subcellular basis responsible for the loss of vasoreactivity in atherosclerotic vessels. We have chosen to focus on the potential of oxidized low density lipoprotein (oxLDL), an important atherogenic agent, to alter sarcoplasmic reticulum (SR) structure and function. Vascular smooth muscle cells (VSMCs) were exposed for 1 to 6 days to low concentrations of minimally oxidized LDL. ATP was used to probe SR function in VSMCs. ATP can increase [Ca2+](i) in control VSMCs because of a release of Ca2+ from the SR. However, after chronic exposure to oxLDL, cells lose their ability to increase [Ca2+](i) in response to ATP. These cells also exhibit a depressed rise in [Ca2+](i) after exposure to ryanodine. These effects were associated with a decreased immunoreactivity for the ryanodine-sensitive Ca2+-release channels in the SR of oxLDL-treated cells. Immunohistochemical analysis of aortic sections obtained from rabbits fed a cholesterol- supplemented diet revealed a significant decrease in the immunoreactivity for ryanodine channels in the plaque and in the medial layer underlying the plaque. In summary, our data identify oxLDL as a component within the atherosclerotic milieu capable of inducing a decrease in smooth muscle ryanodine channel density. This alteration is associated with a significant defect in the ability of the SR within the smooth muscle cell to regulate Ca2+. These lesions may contribute to the altered vasoreactivity exhibited by atherosclerotic vessels.

Original languageEnglish
Pages (from-to)328-334
Number of pages7
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume20
Issue number2
DOIs
Publication statusPublished - 1 Jan 2000
Externally publishedYes

Fingerprint

Ryanodine
Sarcoplasmic Reticulum
Smooth Muscle Myocytes
Vascular Smooth Muscle
Adenosine Triphosphate
Smooth Muscle
Cholesterol
oxidized low density lipoprotein
Diet
Rabbits

Keywords

  • Atherosclerosis
  • Ca
  • Sarcoplasmic reticulum

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Lesions in ryanodine channels in smooth muscle cells exposed to oxidized low density lipoprotein. / Massaeli, Hamid; Austria, J. Alejandro; Pierce, Grant N.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 20, No. 2, 01.01.2000, p. 328-334.

Research output: Contribution to journalArticle

@article{9a16ab1a2f4345fe8e9928874c6a8017,
title = "Lesions in ryanodine channels in smooth muscle cells exposed to oxidized low density lipoprotein",
abstract = "The purpose of the present investigation was to investigate the subcellular basis responsible for the loss of vasoreactivity in atherosclerotic vessels. We have chosen to focus on the potential of oxidized low density lipoprotein (oxLDL), an important atherogenic agent, to alter sarcoplasmic reticulum (SR) structure and function. Vascular smooth muscle cells (VSMCs) were exposed for 1 to 6 days to low concentrations of minimally oxidized LDL. ATP was used to probe SR function in VSMCs. ATP can increase [Ca2+](i) in control VSMCs because of a release of Ca2+ from the SR. However, after chronic exposure to oxLDL, cells lose their ability to increase [Ca2+](i) in response to ATP. These cells also exhibit a depressed rise in [Ca2+](i) after exposure to ryanodine. These effects were associated with a decreased immunoreactivity for the ryanodine-sensitive Ca2+-release channels in the SR of oxLDL-treated cells. Immunohistochemical analysis of aortic sections obtained from rabbits fed a cholesterol- supplemented diet revealed a significant decrease in the immunoreactivity for ryanodine channels in the plaque and in the medial layer underlying the plaque. In summary, our data identify oxLDL as a component within the atherosclerotic milieu capable of inducing a decrease in smooth muscle ryanodine channel density. This alteration is associated with a significant defect in the ability of the SR within the smooth muscle cell to regulate Ca2+. These lesions may contribute to the altered vasoreactivity exhibited by atherosclerotic vessels.",
keywords = "Atherosclerosis, Ca, Sarcoplasmic reticulum",
author = "Hamid Massaeli and Austria, {J. Alejandro} and Pierce, {Grant N.}",
year = "2000",
month = "1",
day = "1",
doi = "10.1161/01.ATV.20.2.328",
language = "English",
volume = "20",
pages = "328--334",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Lesions in ryanodine channels in smooth muscle cells exposed to oxidized low density lipoprotein

AU - Massaeli, Hamid

AU - Austria, J. Alejandro

AU - Pierce, Grant N.

PY - 2000/1/1

Y1 - 2000/1/1

N2 - The purpose of the present investigation was to investigate the subcellular basis responsible for the loss of vasoreactivity in atherosclerotic vessels. We have chosen to focus on the potential of oxidized low density lipoprotein (oxLDL), an important atherogenic agent, to alter sarcoplasmic reticulum (SR) structure and function. Vascular smooth muscle cells (VSMCs) were exposed for 1 to 6 days to low concentrations of minimally oxidized LDL. ATP was used to probe SR function in VSMCs. ATP can increase [Ca2+](i) in control VSMCs because of a release of Ca2+ from the SR. However, after chronic exposure to oxLDL, cells lose their ability to increase [Ca2+](i) in response to ATP. These cells also exhibit a depressed rise in [Ca2+](i) after exposure to ryanodine. These effects were associated with a decreased immunoreactivity for the ryanodine-sensitive Ca2+-release channels in the SR of oxLDL-treated cells. Immunohistochemical analysis of aortic sections obtained from rabbits fed a cholesterol- supplemented diet revealed a significant decrease in the immunoreactivity for ryanodine channels in the plaque and in the medial layer underlying the plaque. In summary, our data identify oxLDL as a component within the atherosclerotic milieu capable of inducing a decrease in smooth muscle ryanodine channel density. This alteration is associated with a significant defect in the ability of the SR within the smooth muscle cell to regulate Ca2+. These lesions may contribute to the altered vasoreactivity exhibited by atherosclerotic vessels.

AB - The purpose of the present investigation was to investigate the subcellular basis responsible for the loss of vasoreactivity in atherosclerotic vessels. We have chosen to focus on the potential of oxidized low density lipoprotein (oxLDL), an important atherogenic agent, to alter sarcoplasmic reticulum (SR) structure and function. Vascular smooth muscle cells (VSMCs) were exposed for 1 to 6 days to low concentrations of minimally oxidized LDL. ATP was used to probe SR function in VSMCs. ATP can increase [Ca2+](i) in control VSMCs because of a release of Ca2+ from the SR. However, after chronic exposure to oxLDL, cells lose their ability to increase [Ca2+](i) in response to ATP. These cells also exhibit a depressed rise in [Ca2+](i) after exposure to ryanodine. These effects were associated with a decreased immunoreactivity for the ryanodine-sensitive Ca2+-release channels in the SR of oxLDL-treated cells. Immunohistochemical analysis of aortic sections obtained from rabbits fed a cholesterol- supplemented diet revealed a significant decrease in the immunoreactivity for ryanodine channels in the plaque and in the medial layer underlying the plaque. In summary, our data identify oxLDL as a component within the atherosclerotic milieu capable of inducing a decrease in smooth muscle ryanodine channel density. This alteration is associated with a significant defect in the ability of the SR within the smooth muscle cell to regulate Ca2+. These lesions may contribute to the altered vasoreactivity exhibited by atherosclerotic vessels.

KW - Atherosclerosis

KW - Ca

KW - Sarcoplasmic reticulum

UR - http://www.scopus.com/inward/record.url?scp=0033964670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033964670&partnerID=8YFLogxK

U2 - 10.1161/01.ATV.20.2.328

DO - 10.1161/01.ATV.20.2.328

M3 - Article

C2 - 10669627

AN - SCOPUS:0033964670

VL - 20

SP - 328

EP - 334

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 2

ER -